Kane Biotech Receives Offer for its Interest in STEM Animal Health
December 20, 2023 08:29 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on December 19, 2023, it signed a...
Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
December 06, 2023 08:19 ET
|
Gallant Therapeutics
Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
Kane Biotech Announces Improved Third Quarter 2023 Financial Results
November 28, 2023 16:05 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third...
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
November 21, 2023 07:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Enhancing Animal Welfare: How AI is Reshaping Diagnosis and Treatment in Animal Health
November 20, 2023 10:53 ET
|
Research and Markets
Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) In Animal Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been...
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 08, 2023 16:00 ET
|
Dyadic International, Inc.
Received an upfront payment of $0.6 million in October for product development and licensing of our Dapibus™ platform for animal-free dairy enzyme productsDYAI-100 Phase 1 clinical trial top-line...
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
October 25, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Digital Ally Appoints New Member of the Board of Directors
October 17, 2023 08:10 ET
|
Digital Ally, Inc.
LENEXA, KS., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (the “Company”) (Nasdaq: DGLY), today announced that the Board of Directors (the “Board”) of the Company appointed D. Duke Daughtery...
Veterinary Diagnostics Market $7.27 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 11, 2023 07:47 ET
|
The Insight Partners
Pune, India, Oct. 11, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Veterinary Diagnostics Market Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth...
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...